Regional Analysis

Pharma grade Magnesium Trisilicate Market – Regional Analysis

On the basis of region, the global pharma grade magnesium trisilicate market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America region is expected to hold dominant position in pharma grade magnesium trisilicate market, owing to rising prevalence of gastric ulcer caused by H. pylori infection. For instance, Centers for Disease Control and Prevention (CDC) of U.S. statistics 2014, stated that about 30 to 40 percent of people in the U.S. suffer from H. pylori infection, which is associated with gastric ulcer. Thus, this statistics suggests rising demand for antacid, in turn fueling growth of pharma grade magnesium trisilicate market.

Asia Pacific region is anticipated to witness significant growth in the global pharma grade magnesium trisilicate market due to rising involvement of key players in organizing business exhibitions. For instance, Tominta Pharmaceutical Co. Ltd., is participating in Convention on Pharmaceutical Ingredients (CPhI) and Pharmaceutical Machinery and Equipment Convention (P-MEC) event in December 2018, in India to help companies for adopting latest trends and innovations in the pharmaceutical market and active pharmaceutical ingredients.